We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Says Sponsors May Extrapolate Adult Data for Pediatric Anti-Infective Drug Development
FDA Says Sponsors May Extrapolate Adult Data for Pediatric Anti-Infective Drug Development
The FDA will allow sponsors to extrapolate efficacy results from adult studies to use in pediatric studies of anti-infective drugs, as long as the disease process and the effects of the drug are similar in both populations.